Monitoring for and Characterizing Crizotinib Progression: A Chart Review of ALK-Positive Non-Small Cell Lung Cancer Patients
暂无分享,去创建一个
Anand A. Dalal | A. Macalalad | A. Guérin | K. Culver | M. Sasané | P. Galebach | E. Bendaly | I. Bocharova | R. Foster | A. Guerin | M. Sasane